VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

Stock Comparison

Danaher Corporation vs Stevanato Group S.p.A.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Danaher Corporation

DHR · New York Stock Exchange

Market cap (USD)$122.3B
Gross margin (TTM)60.7%
Operating margin (TTM)21%
Net margin (TTM)14.9%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
Data as of2026-05-27
Moat score
77/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Danaher Corporation's moat claims, evidence, and risks.

View DHR analysis

Stevanato Group S.p.A.

STVN · New York Stock Exchange

Market cap (USD)$4.9B
Gross margin (TTM)29%
Operating margin (TTM)16.6%
Net margin (TTM)11.8%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryIT
Data as of2026-05-27
Moat score
61/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Stevanato Group S.p.A.'s moat claims, evidence, and risks.

View STVN analysis

Comparison highlights

  • Moat score gap: Danaher Corporation leads (77 / 100 vs 61 / 100 for Stevanato Group S.p.A.).
  • Segment focus: Danaher Corporation has 3 segments (40.6% in Diagnostics); Stevanato Group S.p.A. has 3 segments (47% in High-Value Solutions).
  • Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
  • Moat breadth: Danaher Corporation has 7 moat types across 3 domains; Stevanato Group S.p.A. has 8 across 3.

Primary market context

Danaher Corporation

Diagnostics

Market

In vitro diagnostics instruments, consumables, software and services (clinical lab, acute care/POC, pathology, molecular diagnostics)

Geography

Global

Customer

Hospitals, physician offices, reference laboratories, pathology labs, critical care settings

Role

IVD device manufacturer and reagent/test supplier + software/services

Revenue share

40.6%

Stevanato Group S.p.A.

High-Value Solutions

Market

High-value primary packaging and integrated solutions for injectable drugs

Geography

Global

Customer

Pharmaceutical, biotechnology, and life sciences companies; fill-finish CMOs

Role

Primary packaging/component manufacturer (ready-to-use), plus supporting services

Revenue share

47%

Side-by-side metrics

Danaher Corporation
Stevanato Group S.p.A.
Ticker / Exchange
DHR - New York Stock Exchange
STVN - New York Stock Exchange
Market cap (USD)
$122.3B
$4.9B
Gross margin (TTM)
60.7%
29%
Operating margin (TTM)
21%
16.6%
Net margin (TTM)
14.9%
11.8%
Sector
Healthcare
Healthcare
Industry
Medical - Diagnostics & Research
Medical - Instruments & Supplies
HQ country
US
IT
Primary segment
Diagnostics
High-Value Solutions
Market structure
Oligopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Strong
Moat score
77 / 100
61 / 100
Moat domains
Demand, Supply, Legal
Demand, Supply, Network
Last update
2026-05-27
2026-05-27

Moat coverage

Shared moat types

Design In QualificationService Field NetworkOperational Excellence

Danaher Corporation strengths

Installed Base ConsumablesLearning Curve YieldRegulated Standards PipeSuite Bundling

Stevanato Group S.p.A. strengths

Capex Knowhow ScaleDe Facto StandardBrand TrustLong Term ContractsScope Economies

Segment mix

Danaher Corporation segments

Full profile >

Biotechnology

Oligopoly

30.2%

Life Sciences

Oligopoly

29.2%

Diagnostics

Oligopoly

40.6%

Stevanato Group S.p.A. segments

Full profile >

High-Value Solutions

Oligopoly

47%

Other Containment and Delivery Solutions

Competitive

44%

Engineering

Competitive

9%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.